JPH09505597A - 3−アシルアミノベンゾアゼピン類 - Google Patents
3−アシルアミノベンゾアゼピン類Info
- Publication number
- JPH09505597A JPH09505597A JP7515168A JP51516895A JPH09505597A JP H09505597 A JPH09505597 A JP H09505597A JP 7515168 A JP7515168 A JP 7515168A JP 51516895 A JP51516895 A JP 51516895A JP H09505597 A JPH09505597 A JP H09505597A
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- acid
- methyl
- compound
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 次の構造式I及び構造式IIで表される化合物、又は、前記化合物の医薬上 許容可能な塩、水和物、結晶形態であって、 前式中で、Rが、C1からC6の直鎖もしくは枝分れアルキル、アリールアルキル 、アリール、ヘテロアリール、O−アルキル、O−アシル、カルボン酸、アルデ ヒド、ケトン、エステル、又は、アミドであり、R′が、C1からC6の直鎖もし くは枝分れアルキル、アリールアルキル、アリール、N−アルキル、N−アリー ル、O−アルキル、又は、O−アリールであり、R″が、直鎖もしくは枝分れア ルキル又はアリールである前記化合物。 2. 次の表に示すものから成るグループから選択される請求項1に記載の化合 物。 3. 次の表に示すものから成るグループから選択される請求項1に記載の化合 物。 4. 次の表に示すものから成るグループから選択される請求項1に記載の化合 物。 5. 医薬上許容可能な担体と、治療有効量の請求項1に記載の化合物又はその 医薬上許容可能な塩、結晶形態、もしくは水和物とを含む医薬調合物。 6. 別の抗不整脈薬又は他の心臓血管薬剤を更に含む請求項5に記載の医薬調 合物。 7. 抗不整脈有効量の請求項1に記載の化合物を、不整脈の 予防又は治療を要する非ヒト患者に投与することを含む不整脈の予防又は治療の ための方法。 8. 別の抗不整脈薬又は他の心臓血管薬剤を併用することを含む請求項7に記 載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15634893A | 1993-11-22 | 1993-11-22 | |
US156,348 | 1993-11-22 | ||
PCT/US1994/013413 WO1995014671A1 (en) | 1993-11-22 | 1994-11-21 | 3-acylaminobenzazepines |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09505597A true JPH09505597A (ja) | 1997-06-03 |
Family
ID=22559195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7515168A Ceased JPH09505597A (ja) | 1993-11-22 | 1994-11-21 | 3−アシルアミノベンゾアゼピン類 |
Country Status (12)
Country | Link |
---|---|
US (1) | US5696111A (ja) |
EP (1) | EP0730581B1 (ja) |
JP (1) | JPH09505597A (ja) |
AT (1) | ATE206402T1 (ja) |
AU (1) | AU681924B2 (ja) |
CA (1) | CA2176019A1 (ja) |
DE (1) | DE69428546T2 (ja) |
DK (1) | DK0730581T3 (ja) |
ES (1) | ES2162907T3 (ja) |
GR (1) | GR3036814T3 (ja) |
PT (1) | PT730581E (ja) |
WO (1) | WO1995014671A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002516313A (ja) * | 1997-01-31 | 2002-06-04 | セルジーン・コーポレーシヨン | 2−置換ピペリジン立体異性体を製造するための方法及び中間体 |
US6784192B2 (en) | 2000-01-20 | 2004-08-31 | Eisai Co., Ltd. | Piperidine compound and pharmaceutical composition thereof |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994026718A1 (en) * | 1993-05-13 | 1994-11-24 | Yoshitomi Pharmaceutical Industries, Ltd. | 3-aminoazepine compound and pharmaceutical use thereof |
MX9702507A (es) * | 1994-10-04 | 1997-07-31 | Pfizer | Nuevos intermedios y procedimientos para preparar antagonistas cck. |
US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6683075B1 (en) | 1996-12-23 | 2004-01-27 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use |
US6509331B1 (en) | 1998-06-22 | 2003-01-21 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
US6528505B1 (en) | 1998-06-22 | 2003-03-04 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6569851B1 (en) | 1998-06-22 | 2003-05-27 | Elan Pharmaceutials, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6774125B2 (en) | 1998-06-22 | 2004-08-10 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
AR079170A1 (es) * | 2009-12-10 | 2011-12-28 | Lilly Co Eli | Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
JP7299350B2 (ja) * | 2019-05-31 | 2023-06-27 | メッドシャイン ディスカバリー インコーポレイテッド | Rip-1キナーゼ阻害剤としての二環式化合物およびその使用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT75373B (en) * | 1981-08-12 | 1986-06-18 | Agripat Sa | Process for the preparation of tinted contact lenses |
DE3134672A1 (de) * | 1981-09-02 | 1983-03-17 | Boehringer Ingelheim KG, 6507 Ingelheim | Heterocyclische verbindungen, ihre herstellung und verwendung |
US4473575A (en) * | 1982-07-19 | 1984-09-25 | Ciba-Geigy Corporation | 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids |
DE3373469D1 (en) * | 1982-09-30 | 1987-10-15 | Merck & Co Inc | 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents |
DK151808C (da) * | 1982-11-16 | 1988-06-20 | Ferrosan As | Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater |
US4470988A (en) * | 1983-02-10 | 1984-09-11 | Ciba-Geigy Corporation | Benzazocinone and benzazoninone derivatives, and their pharmaceutical use |
US4537885A (en) * | 1983-02-10 | 1985-08-27 | Ciba Geigy Corporation | Certain benzazocinone and benzazoninone derivatives |
NZ210850A (en) * | 1984-01-19 | 1988-10-28 | Hoffmann La Roche | Imidazodiazepine derivatives and pharmaceutical compositions |
US4600534A (en) * | 1984-02-06 | 1986-07-15 | Ciba-Geigy Corporation | Process and intermediates for manufacture of 3-(5-amino-1-carboxypentylamino)-tetrahydro-1-benzazepin-2-one-1-acetic acid |
US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
DE3786389T2 (de) * | 1986-10-13 | 1993-11-04 | Sumitomo Dow Ltd | Waermebestaendige thermoplastische harzzusammensetzung. |
US4847248A (en) * | 1986-12-23 | 1989-07-11 | Merck & Co., Inc. | 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists |
EP0322779A3 (en) * | 1987-12-29 | 1991-05-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzolactam compounds and pharmaceutical uses thereof |
IT215722Z2 (it) * | 1989-02-21 | 1990-10-26 | Giancarlo De Giacomi | Occhiali con specchietti retrovisori orientabili in tutte le direzioni. |
US5206234A (en) * | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
DE4125457A1 (de) * | 1991-08-01 | 1993-02-04 | Bayer Ag | Verfahren zur herstellung von n-substituierten lactamen |
WO1993008175A1 (en) * | 1991-10-24 | 1993-04-29 | Glaxo Group Limited | Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin |
TW213901B (ja) * | 1992-01-27 | 1993-10-01 | Pfizer | |
IT1254558B (it) * | 1992-03-26 | 1995-09-25 | Mini Ricerca Scient Tecnolog | Composti a base di 3,4-diaril-(5h)-furan-2-one ad attivita' fungicida 3 |
WO1994026718A1 (en) * | 1993-05-13 | 1994-11-24 | Yoshitomi Pharmaceutical Industries, Ltd. | 3-aminoazepine compound and pharmaceutical use thereof |
JPH09314058A (ja) * | 1996-05-31 | 1997-12-09 | Toshiba Eng Co Ltd | 異物捕捉装置 |
-
1994
- 1994-11-21 DK DK95901954T patent/DK0730581T3/da active
- 1994-11-21 US US08/646,368 patent/US5696111A/en not_active Expired - Fee Related
- 1994-11-21 AT AT95901954T patent/ATE206402T1/de not_active IP Right Cessation
- 1994-11-21 PT PT95901954T patent/PT730581E/pt unknown
- 1994-11-21 AU AU11004/95A patent/AU681924B2/en not_active Ceased
- 1994-11-21 ES ES95901954T patent/ES2162907T3/es not_active Expired - Lifetime
- 1994-11-21 JP JP7515168A patent/JPH09505597A/ja not_active Ceased
- 1994-11-21 DE DE69428546T patent/DE69428546T2/de not_active Expired - Fee Related
- 1994-11-21 WO PCT/US1994/013413 patent/WO1995014671A1/en active IP Right Grant
- 1994-11-21 CA CA002176019A patent/CA2176019A1/en not_active Abandoned
- 1994-11-21 EP EP95901954A patent/EP0730581B1/en not_active Expired - Lifetime
-
2001
- 2001-10-05 GR GR20010401427T patent/GR3036814T3/el not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002516313A (ja) * | 1997-01-31 | 2002-06-04 | セルジーン・コーポレーシヨン | 2−置換ピペリジン立体異性体を製造するための方法及び中間体 |
US6784192B2 (en) | 2000-01-20 | 2004-08-31 | Eisai Co., Ltd. | Piperidine compound and pharmaceutical composition thereof |
Also Published As
Publication number | Publication date |
---|---|
AU1100495A (en) | 1995-06-13 |
EP0730581A4 (en) | 1997-02-05 |
ES2162907T3 (es) | 2002-01-16 |
WO1995014671A1 (en) | 1995-06-01 |
US5696111A (en) | 1997-12-09 |
GR3036814T3 (en) | 2002-01-31 |
AU681924B2 (en) | 1997-09-11 |
DE69428546D1 (en) | 2001-11-08 |
ATE206402T1 (de) | 2001-10-15 |
PT730581E (pt) | 2002-02-28 |
EP0730581B1 (en) | 2001-10-04 |
CA2176019A1 (en) | 1995-06-01 |
EP0730581A1 (en) | 1996-09-11 |
DK0730581T3 (da) | 2001-11-26 |
DE69428546T2 (de) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09505597A (ja) | 3−アシルアミノベンゾアゼピン類 | |
AU695159B2 (en) | Antiarrhythmic benzodiazepines | |
JP2840454B2 (ja) | ベンゾジアゼピン類 | |
US4663321A (en) | Triazolobenzodiazepines and pharmaceutical use | |
CA2324475A1 (en) | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds | |
JP2002518481A (ja) | β−アミロイドペプチドの放出および/またはその合成を阻害するための化合物 | |
JPH10504570A (ja) | 2,3−ジヒドロ−1−(2,2,2−トリフルオロエチル)−2−オキソ−5−フェニル−1h−1,4−ベンゾジアゼピン | |
US5302591A (en) | Benzodiazepine derivatives | |
JP2002518482A (ja) | β−アミロイドペプチド放出および/またはその合成を阻害する化合物 | |
JP3010558B2 (ja) | 新規の1,7‐融合1h‐インドール‐2‐カルボン酸‐n‐(1,4‐ベンゾジアゼピン‐3‐イル)‐アミド、その製法及びこれを含有するコレシストキニン拮抗作用薬剤 | |
US5218114A (en) | Cholecystokinin antagonists | |
AU722110B2 (en) | Pharmaceutical preparation | |
US5817654A (en) | N-substituted naphthofused lactams | |
JPH09500392A (ja) | 抗不整脈性ベンゾジアゼピン類 | |
US5218115A (en) | Cholecystokinin antagonists | |
EP0166356B1 (en) | 2-substituted-aminomethyl-1,4-benzodiazepines, process for their preparation and pharmaceutical compositions containing them | |
AU2005321462A1 (en) | 5-HT7 receptor antagonists | |
JP2001512731A (ja) | AMPA/Kainate受容体阻害剤としての1,3−ジオキソロ/4,5−H/2,3/ベンゾジアゼピン誘導体 | |
NZ328938A (en) | Arrhythmia treatment using benzodiazepine derivatives | |
JPH09500396A (ja) | 新規フラノジアゼピン類 | |
JP2001520197A (ja) | 抗不整脈薬として有効な新規なベンゾジアゼピン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040127 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040416 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040607 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20040913 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20041026 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20040106 |